METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)

The article shows the feasibility of detecting and monitoring primary breast diffuse large B-cell lymphoma using single-photon emission computed tomography (SPECT) with 99mTc-1-thio-D-glucose (99mТс-TG), a new radiopharmaceutical. The innovative radiopharmaceutical makes it possible to evaluate the...

Full description

Bibliographic Details
Main Authors: Ye. A. Dudnikova, V. I. Chernov, A. V. Muravleva, T. L. Kravchuk, R. V. Zelchan, A. A. Medvedeva, O. D. Bragina, Ye. L. Simolina, N. O. Popova, V. V. Vysockaja, N. M. Lukina, V. A. Shatalova, O. V. Shpileva, A. V. Goldberg, V. Ye. Goldberg
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2020-10-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/1589
_version_ 1826563692107399168
author Ye. A. Dudnikova
V. I. Chernov
A. V. Muravleva
T. L. Kravchuk
R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
Ye. L. Simolina
N. O. Popova
V. V. Vysockaja
N. M. Lukina
V. A. Shatalova
O. V. Shpileva
A. V. Goldberg
V. Ye. Goldberg
author_facet Ye. A. Dudnikova
V. I. Chernov
A. V. Muravleva
T. L. Kravchuk
R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
Ye. L. Simolina
N. O. Popova
V. V. Vysockaja
N. M. Lukina
V. A. Shatalova
O. V. Shpileva
A. V. Goldberg
V. Ye. Goldberg
author_sort Ye. A. Dudnikova
collection DOAJ
description The article shows the feasibility of detecting and monitoring primary breast diffuse large B-cell lymphoma using single-photon emission computed tomography (SPECT) with 99mTc-1-thio-D-glucose (99mТс-TG), a new radiopharmaceutical. The innovative radiopharmaceutical makes it possible to evaluate the metabolism of tumor tissue without using positron emission tomography. The findings of 99mTc-TG SPECT obtained during diagnosis and monitoring of the patient were confirmed by the results of computed tomography. A comprehensive examination of the patient, including 99mTc-TG SPECT, made it possible to diagnose a rare case of primary breast lymphoma. Primary breast lymphoma accounts for 1.7–2.2 % of all extranodal nonHodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histological type occurring usually as a unilateral palpable tumor in middle-aged women. Extranodal lymphomas account for less than 0.5 % of all malignant neoplasms of the breast. After 6 courses of immunochemotherapy, the patient underwent 99mTc-TG SPECT, which demonstrated persistent hypermetabolic activity in the breast. The patient received radiation therapy to the remaining tumor of the left breast. The patient is in remission and followed up at the Cancer Research Institute of Tomsk National Research Medical Center. Thus, 99mTc-TG SPECT is believed to be a promising method for visualizing primary breast lymphomas and assessing their treatment outcomes. It is an alternative to the standard approach using 18F-FDG positron emission tomography. The method compares favorably with positron emission tomography with its wide availability and low cost of study.
first_indexed 2024-04-10T01:52:27Z
format Article
id doaj.art-a52909e1f2414a11beebbbb4b525b5d7
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2025-03-14T10:08:00Z
publishDate 2020-10-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-a52909e1f2414a11beebbbb4b525b5d72025-03-02T11:16:13ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682020-10-0119514515310.21294/1814-4861-2020-19-5-145-153798METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)Ye. A. Dudnikova0V. I. Chernov1A. V. Muravleva2T. L. Kravchuk3R. V. Zelchan4A. A. Medvedeva5O. D. Bragina6Ye. L. Simolina7N. O. Popova8V. V. Vysockaja9N. M. Lukina10V. A. Shatalova11O. V. Shpileva12A. V. Goldberg13V. Ye. Goldberg14Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences; Research Centrum for Oncotheranostics, Tomsk Polytechnic UniversityCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of SciencesThe article shows the feasibility of detecting and monitoring primary breast diffuse large B-cell lymphoma using single-photon emission computed tomography (SPECT) with 99mTc-1-thio-D-glucose (99mТс-TG), a new radiopharmaceutical. The innovative radiopharmaceutical makes it possible to evaluate the metabolism of tumor tissue without using positron emission tomography. The findings of 99mTc-TG SPECT obtained during diagnosis and monitoring of the patient were confirmed by the results of computed tomography. A comprehensive examination of the patient, including 99mTc-TG SPECT, made it possible to diagnose a rare case of primary breast lymphoma. Primary breast lymphoma accounts for 1.7–2.2 % of all extranodal nonHodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histological type occurring usually as a unilateral palpable tumor in middle-aged women. Extranodal lymphomas account for less than 0.5 % of all malignant neoplasms of the breast. After 6 courses of immunochemotherapy, the patient underwent 99mTc-TG SPECT, which demonstrated persistent hypermetabolic activity in the breast. The patient received radiation therapy to the remaining tumor of the left breast. The patient is in remission and followed up at the Cancer Research Institute of Tomsk National Research Medical Center. Thus, 99mTc-TG SPECT is believed to be a promising method for visualizing primary breast lymphomas and assessing their treatment outcomes. It is an alternative to the standard approach using 18F-FDG positron emission tomography. The method compares favorably with positron emission tomography with its wide availability and low cost of study.https://www.siboncoj.ru/jour/article/view/1589radiopharmaceutical99mtc-1-thio-d-glucosesingle-photon emission computed tomographyprimary breast lymphomapositron emission tomography
spellingShingle Ye. A. Dudnikova
V. I. Chernov
A. V. Muravleva
T. L. Kravchuk
R. V. Zelchan
A. A. Medvedeva
O. D. Bragina
Ye. L. Simolina
N. O. Popova
V. V. Vysockaja
N. M. Lukina
V. A. Shatalova
O. V. Shpileva
A. V. Goldberg
V. Ye. Goldberg
METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
Сибирский онкологический журнал
radiopharmaceutical
99mtc-1-thio-d-glucose
single-photon emission computed tomography
primary breast lymphoma
positron emission tomography
title METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
title_full METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
title_fullStr METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
title_full_unstemmed METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
title_short METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)
title_sort metabolic single photon emission computed tomography with the new radiopharmaceutical ⁹⁹ᵐtc 1 thio d glucose in the diagnosis and monitoring of the primary breast lymphoma case report
topic radiopharmaceutical
99mtc-1-thio-d-glucose
single-photon emission computed tomography
primary breast lymphoma
positron emission tomography
url https://www.siboncoj.ru/jour/article/view/1589
work_keys_str_mv AT yeadudnikova metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT vichernov metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT avmuravleva metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT tlkravchuk metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT rvzelchan metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT aamedvedeva metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT odbragina metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT yelsimolina metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT nopopova metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT vvvysockaja metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT nmlukina metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT vashatalova metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT ovshpileva metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT avgoldberg metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport
AT vyegoldberg metabolicsinglephotonemissioncomputedtomographywiththenewradiopharmaceutical99mtc1thiodglucoseinthediagnosisandmonitoringoftheprimarybreastlymphomacasereport